Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Avigen Inc.

Division of MediciNova Inc.
www.avigen.com

Latest From Avigen Inc.

Stockwatch: UniQure's guile and the dubious promise of gene therapy

After last week's headline-grabbing deal between Bristol Myers Squibb (BMS) and Dutch gene therapy company uniQure (scripintelligence.com, 6 April 2015), who would have thought that events in Europe might by the end of the week spell the demise of uniQure's gene therapy platform?

Cardiovascular Cancer

CHOP Commits $50 Million To Gene Therapy Spin-Out Spark Therapeutics

Non-profit hospital spins out its first start-up, which will house one program to address a heritable form of blindness, another to treat hemophilia B.

BioPharmaceutical Business Strategies

Will a pharma-shaped pin burst the biotech bubble?

This year, a combination of elements has combined to create a meteoric rise in biotech fortunes. But how long will it last? And will H2 see a reversal of riches? Andy Smith explores the inside of the biotech bubble.

Cancer Orthopedics

Katama Pharmaceuticals Inc.

Katama Pharmaceuticals Inc. was built around tolperisone, a generic, oral small molecule muscle relaxant manufactured and sold in Europe for the treatment of muscular pain and neuromuscular spasms. Katama aims to launch its version in the US, initially for treating acute lower back pain.

BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • MediciNova Inc.
  • Senior Management
  • Andrew Sauter, CEO
    Kirk W Johnson, PhD, VP, R&D
  • Contact Info
  • Avigen Inc.
    Phone: (510) 748-7150
    1301 Harbor Bay Pkwy
    Alameda, CA 94502
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register